Edgewise Therapeutics, Inc. (EWTX) ownership: Top institutional holder: ORBIMED ADVISORS LLC ($488.83M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 15518492.00 | $488.83M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 10428437.00 | $328.50M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | 7365038.00 | $232.00M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 6575940.00 | $207.14M | 2026-03-31 |
| BlackRock, Inc. | 6472991.00 | $203.90M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 5915556.00 | $186.29M | 2026-03-31 |
| NOVO HOLDINGS A/S | 5350000.00 | $168.53M | 2026-03-31 |
| Driehaus Capital Management LLC | 4477942.00 | $141.06M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-05-04 | |
| Sell | null | 2026-05-04 | |
| Sell | null | 2026-05-04 | |
| Sell | null | 2026-05-04 |
Back to EWTX overview · EWTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.